SKK:NASDAQSKK Holdings Limited Analysis
Data as of 2026-05-01 - not real-time
$1.77
Latest Price
8/10Risk
Risk Level: High
Executive Summary
SKK Holdings is trading at $1.77, well below its 20‑day ($2.10), 50‑day ($2.42) and 200‑day ($3.49) simple moving averages, signaling a sustained bearish price trend. Technical indicators such as an RSI of 37.8 and a bearish MACD histogram reinforce the downside momentum, while volume has been decreasing, indicating waning buying interest. The stock’s beta of 0.28 suggests limited market‑wide volatility, yet its 30‑day realized volatility of 127% and a historic max drawdown of –78% expose extreme price swings. Fundamentally, the company is under severe strain: revenue is contracting (-4.6%), operating margin is –38%, and both operating and free cash flow are deeply negative. Debt is overwhelming with a debt‑to‑equity ratio of 164, and the balance sheet shows a book value per share of just $0.39 versus a price‑to‑book multiple of 4.6. No dividend is paid, and earnings per share are negative, leaving no earnings cushion. Recent material news reveals a Nasdaq deficiency notice for not meeting the minimum price requirement, prompting a 1‑for‑10 reverse stock split scheduled for April 6 2026. While the split may temporarily lift the share price, it underscores regulatory risk and the company’s precarious listing status. The market’s “Extreme Greed” sentiment (fear‑greed index 90.9) appears disconnected from the underlying financial distress. Overall, the combination of weak fundamentals, adverse technical signals, and regulatory pressure makes the stock highly speculative. Investors should treat SKK as a high‑risk position with limited upside potential.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 8/10
Key Factors
- Nasdaq minimum price deficiency and pending reverse split
- Bearish technical setup (price below all SMAs, MACD bearish)
- Severe financial weakness (negative margins, high debt)
Medium Term
1–3 yearsCautious
Model confidence: 7/10
Key Factors
- Continued negative cash flow and earnings
- Uncertainty around post‑split liquidity and market acceptance
- Elevated volatility and large historic drawdown
Long Term
> 3 yearsCautious
Model confidence: 6/10
Key Factors
- Fundamental turnaround unlikely without major capital restructuring
- Persistent regulatory risk of delisting if compliance not achieved
- Lack of dividend or earnings growth prospects
Key Metrics & Analysis
Financial Health
Revenue Growth-4.60%
Profit Margin-22.55%
ROE-40.22%
ROA-5.49%
Debt/Equity164.42
P/B Ratio4.6
Op. Cash Flow$-512000
Free Cash Flow$-3104375
Industry P/E31.5
Technical Analysis
TrendBearish
RSI37.8
Support$1.61
Resistance$2.68
MA 20$2.10
MA 50$2.42
MA 200$3.49
MACDBearish
VolumeDecreasing
Fear & Greed Index90.89
Valuation
GradeOvervalued
TypeValue
Risk Assessment
Beta0.28
Volatility127.35%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.